Using deep transcranial magnetic stimulation to improve insight in high-risk individuals for schizophrenia
Official title: Targeted Intervention Study of Deep Transcranial Magnetic Stimulation for Impaired Insight in Patients with High-Risk and First-Episode Psychosis
Run by Shanghai Mental Health Center · NCT06831877 · Data updated 2026-11-12
This study is testing if a brain stimulation treatment can help people at high risk for schizophrenia better understand their condition.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 15 Years to 35 Years |
| Sex | All |
| Enrollment | 138 (estimated) |
| Sponsor | Shanghai Mental Health Center Academic / other |
| Locations | 1 site (Shanghai, Shanghai Municipality) |
| Status | Recruiting |
| Started | December 1, 2023 |
| Main results expected | December 31, 2025 |
| Study ends | September 30, 2026 |
| Registry record updated | February 18, 2025 |
| Trial ID | NCT06831877 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals meeting the criteria for clinical high risk for psychosis or those diagnosed with schizophrenia who exhibit impaired insight.
✕Probably not a fit
Patients with established psychotic disorders or those participating in other clinical intervention research may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of deep transcranial magnetic stimulation (dTMS) on enhancing insight in individuals at clinical high risk for psychosis and those experiencing first-episode schizophrenia. It employs a randomized, double-blind, sham-controlled design, administering dTMS over 10 consecutive days with two sessions each day. Participants will be assessed before, immediately after, and at one and three months post-intervention to evaluate changes in insight and the potential predictive role of insight on schizophrenia outcomes. The study aims to understand how modulating brain activity in specific regions can improve clinical insight.
Why it matters
Potential benefit: If successful, this intervention could significantly enhance insight in high-risk individuals, potentially reducing the conversion rate to schizophrenia.
How similar studies have gone: While the approach of using dTMS for this specific purpose is novel, previous studies have shown promise in using similar techniques for other neurological and psychiatric conditions.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Meet the criteria of clinical high risk for psychosis or meet the DSM-V diagnostic criteria for schizophrenia; * Meeting the following definition of impaired insight: below a specific threshold in at least one dimension of the Scale to Assess Unawareness of Mental Disorder (SAI). Specifically, a score of less than 2 in the "awareness of the need for treatment" dimension, less than 3 in the "recognition of illness" dimension, or less than 2 in the "attribution of psychotic symptoms" dimension qualifies an individual as having impaired insight; * Having completed at least six years of primary education; * Being able to give informed consent, oral or written. Patients under 18 years old give oral consent and their next of kin or legal guardians give written consent. Exclusion Criteria: * Participating in any other clinical intervention research; * Meeting the diagnostic criteria of psychotic disorders (including affective disorders); * Threshold symptoms are induced by other mental disorders or psychoactive substances; * Undergoing anti-psychotic medication for more than 2 weeks; * Being diagnosed as organic brain diseases, or severe somatic diseases; * Had Experienced traumatic brain injury, and got scores of 7; * Dementia, or mental retardation (IQ\<70); * Being a condition of scalp infection; * A pacemaker or other metal implants in the body, pregnancy, or claustrophobia.
Where it's running
-
Shanghai Mental Health Center
Shanghai, Shanghai Municipality, China Recruiting
Study contacts
- Study coordinator: Lihua Xu, Doctoral
- Email: mas_xulihua2008@163.com
- Phone: 15000092086
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Sequential Treatment Approaches for Treatment-Resistant Schizophrenia in Chinese Patients
This trial tests whether clozapine-based drug therapy or neuromodulation with MECT or MST is better for adults in China who have treatment-resistant schizophrenia.
-
Online FBT-DBT for Caregivers of Teens with Anorexia Nervosa
This online program tests a combination of family-based and DBT skills to help caregivers of teens with anorexia nervosa manage stress and improve family support.
-
Temporal Interference stimulation for PTSD symptom relief
This study tests whether Temporal Interference stimulation can help reduce PTSD symptoms in adults with PTSD, using twice-daily sessions over a week and follow-up for up to 3 months.
-
Predicting bipolar disorder relapse risk with multi-modal sentiment analysis
This project tests whether combining speech, facial, and other emotional signals can help predict relapse risk in adults with bipolar disorder.
-
Motion-controlled mobile games to improve thinking in people with schizophrenia
This project will try a motion-based smartphone game to improve thinking skills in adults with stable schizophrenia.
-
Gamified somatosensory and narrative rehabilitation to improve thinking and social skills in hospitalized adults with schizophrenia
This trial will test whether an 8-week gamified digital rehabilitation program can improve cognitive and social functioning for hospitalized adults with schizophrenia and whether benefits last over 24 months.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.